IPHA_logo_main_version_h100IPHA_logo_main_version_h100IPHA_logo_main_version_h100IPHA_logo_main_version_h100
  • Home
  • #InnovateForLife
  • News
  • Events
    • IPHA Forum
    • IPHA Conference
    • All other events
  • Publications
    • 2025
      • Industry’s Role in Shaping Ireland’s Life Science Strategy
      • EFPIA Patients Wait Indicator 2024
      • IPHA Position Paper on Fairer and Faster Access to Medicine
    • 2024
      • EFPIA Patient WAIT Indicator Survey
      • Clinical Trials Agreement
      • Making Ireland a European Leader in Clinical Research
    • 2023
      • Achieving Universal Access to New Medicines for Irish Patients
      • Oireachtas briefing
      • IPHA Policy on Supply Outside Reimbursement Final
      • IPHA Self-Care Infographic
    • 2022
      • IPHA reimbursement timelines analysis 2022
      • Factors Affecting the Location of Biopharmaceutical Investments and Implications for European Policy Priorities
      • IHE Cancer Care Comparator Study
      • White Paper on Enterprise
    • 2021
      • Clinical Trials Survey
      • Cell and Gene Pathfinder Study
      • IPHA Codes of Practice
      • Agreement 2021
    • Pre 2020
      • BioPharma Ambition
      • Manifesto for Better Health
      • Innovation and the IP Framework
      • Self-Care: Taking Charge of Your Health
      • Vaccines For Life
      • Perspectives on Ireland’s Medicines Future
  • Submissions
    • 2025
      • IPHA Submission to Department of Foreign Affairs and Trade EU Presidency 2026
      • IPHA Life Science Strategy Submission Dec 25
      • IPHA Response LSS Consultation final 25
      • RD Incentives Consulation_Final 19 May 25
    • 2024
      • IPHA Submission National Rare Disease Strategy 2024
    • 2023
      • Expert Taskforce Submission September 2023 letter
      • Sinn Fein consultation paper Dec 23
  • Code
    • Codes of Practice
    • Transfers of Value
    • Mandatory notification regarding Advisory Board Meetings
    • IPHA Code Training
    • Complaints
  • Clinical & Regulatory
    • Regulation for Innovation
    • Clinical Trials
    • Medicine Safety
    • Regulatory Science Ireland
    • Counterfeit Medicines
  • Self-Care
  • About
    • Members
    • Board of Directors
    • Media Queries
    • Our Team
    • Affiliates Programme
    • Job Opportunities
  • Home
  • #InnovateForLife
  • News
  • Events
    • IPHA Forum
    • IPHA Conference
    • All other events
  • Publications
    • 2025
      • Industry’s Role in Shaping Ireland’s Life Science Strategy
      • EFPIA Patients Wait Indicator 2024
      • IPHA Position Paper on Fairer and Faster Access to Medicine
    • 2024
      • EFPIA Patient WAIT Indicator Survey
      • Clinical Trials Agreement
      • Making Ireland a European Leader in Clinical Research
    • 2023
      • Achieving Universal Access to New Medicines for Irish Patients
      • Oireachtas briefing
      • IPHA Policy on Supply Outside Reimbursement Final
      • IPHA Self-Care Infographic
    • 2022
      • IPHA reimbursement timelines analysis 2022
      • Factors Affecting the Location of Biopharmaceutical Investments and Implications for European Policy Priorities
      • IHE Cancer Care Comparator Study
      • White Paper on Enterprise
    • 2021
      • Clinical Trials Survey
      • Cell and Gene Pathfinder Study
      • IPHA Codes of Practice
      • Agreement 2021
    • Pre 2020
      • BioPharma Ambition
      • Manifesto for Better Health
      • Innovation and the IP Framework
      • Self-Care: Taking Charge of Your Health
      • Vaccines For Life
      • Perspectives on Ireland’s Medicines Future
  • Submissions
    • 2025
      • IPHA Submission to Department of Foreign Affairs and Trade EU Presidency 2026
      • IPHA Life Science Strategy Submission Dec 25
      • IPHA Response LSS Consultation final 25
      • RD Incentives Consulation_Final 19 May 25
    • 2024
      • IPHA Submission National Rare Disease Strategy 2024
    • 2023
      • Expert Taskforce Submission September 2023 letter
      • Sinn Fein consultation paper Dec 23
  • Code
    • Codes of Practice
    • Transfers of Value
    • Mandatory notification regarding Advisory Board Meetings
    • IPHA Code Training
    • Complaints
  • Clinical & Regulatory
    • Regulation for Innovation
    • Clinical Trials
    • Medicine Safety
    • Regulatory Science Ireland
    • Counterfeit Medicines
  • Self-Care
  • About
    • Members
    • Board of Directors
    • Media Queries
    • Our Team
    • Affiliates Programme
    • Job Opportunities
  • Home
  • About Us
  • Contact Us

Sitemap

  • Home
  • Footer links
  • Sitemap
  • About Us
    • Affiliates Programme
    • Board of Directors
    • Executive Team
    • Membership
    • Our Team
  • Access
  • Adopting Innovation
  • Clinical Trials and Regulatory Affairs
    • Clinical Trials
    • Counterfeit Medicines
    • Medicine Safety
    • Regulatory Science Ireland
  • Code
    • Complaints
    • IPHA Code Training
    • Mandatory notification regarding Advisory Board Meetings
  • Codes of Practice
  • Codes of Practice and Transfers of Value
    • Transfers of Value
  • Contact Us
  • Footer links
    • Cookie Policy
    • Privacy Statement
    • Sitemap
    • Terms and Conditions
  • Home
  • Investment
  • IPHA Agreement
  • IPHA EU Elections
  • IPHA News
  • IPHA publications
  • IPHA submissions
  • News
    • Innovation
      • #InnovateForLife
        • 2019
          • Caroline Irwin
          • Cork Harbour
          • Dr Jennifer McAuliffe and Ellen Duggan
          • Dr Orla Cunningham
          • Eoghan Quinn
          • Westport
        • 2020
          • Counting on a Cancer Breakthrough
          • Innovation in the Rural Economy
          • The Impact of Investment
          • The Promise of Science
        • 2021
          • Advancing the Fight Against Obesity
          • Breakthrough Science for Better Health
          • Moving Towards Better Heart Health
          • Pioneering in Dermatology by Looking Beyond Today
          • Pushing the Boundaries of Alzheimer’s Research
        • 2022
          • How science is transforming the lives of HIV patients
          • Innovation in the battle against CLL
          • Navigating precision oncology
          • Six Degrees of Innovation
          • Sizing the therapeutic potential of mRNA
        • 2023
          • A future where cancer isn’t just treated, but cured
          • Ending HIV for everyone, everywhere
          • Innovate Today, Transform Tomorrow
          • Revolutionising drug discovery
        • 2024
          • Because of new cancer medicines – Patrick’s story
          • Because of new medicines – Carmel’s story
          • Because of new medicines – Mary’s story
          • Jen and Leona’s stories
      • #InnovateForVaccines
        • Life-Course Immunisation
      • #InvestInOurFutures
      • #VaccinesWork
        • Role of Vaccines in the Fight Against AMR
        • Vaccine Safety and Monitoring
    • IPHA Events
      • ‘Innovate For Life’, The IPHA Annual Conference 2019
      • All other events
      • Annual Conference 2023
      • Annual Conference 2024
      • Annual Conference 2025
      • IPHA Conference
      • The Digital ThinkIn Series
    • Job Opportunities
  • Price of Medicines
  • Promotion of Medicines
  • Regulation for Innovation
  • Submissions
  • Supply and Reimbursement
  • The Role of Self-Care in a Sustainable Health System
  • ThemeNcode PDF Viewer [Do not Delete]
  • ThemeNcode PDF Viewer SC [Do not Delete]
  • Value of Medicines
  • www.iphacode.ie

Terms and Conditions    |    Privacy Statement   |   Sitemap    |    Cookies


Registered Number: 254776    |    Registered Address: 7 Clanwilliam Terrace, Dublin 2, D02 CC64 Ireland   |  Email: info@ipha.ie

© 2024 IPHA